Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)

NCT03689699 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Adenocarcinoma of the Prostate

Interventions

DRUG: Nivolumab
DRUG: Degarelix
DRUG: BMS-986253

Sponsor

Mark Stein

Collaborators

[object Object]